- Home
- TENX vs RCG Comparison
TENX vs RCG Comparison
Compare TENX & RCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- RCG
- Stock Information
- Founded
- TENX 1967
- RCG 1994
- Country
- TENX United States
- RCG United States
- Employees
- TENX N/A
- RCG N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- RCG Investment Managers
- Sector
- TENX Health Care
- RCG Finance
- Exchange
- TENX Nasdaq
- RCG Nasdaq
- Market Cap
- TENX 11.4M
- RCG 14.3M
- IPO Year
- TENX N/A
- RCG N/A
- Fundamental
- Price
- TENX $3.28
- RCG $2.07
- Analyst Decision
- TENX Strong Buy
- RCG
- Analyst Count
- TENX 2
- RCG 0
- Target Price
- TENX $30.00
- RCG N/A
- AVG Volume (30 Days)
- TENX 32.0K
- RCG 5.9K
- Earning Date
- TENX 11-11-2024
- RCG 01-01-0001
- Dividend Yield
- TENX N/A
- RCG 0.98%
- EPS Growth
- TENX N/A
- RCG N/A
- EPS
- TENX N/A
- RCG N/A
- Revenue
- TENX N/A
- RCG N/A
- Revenue This Year
- TENX N/A
- RCG N/A
- Revenue Next Year
- TENX N/A
- RCG N/A
- P/E Ratio
- TENX N/A
- RCG N/A
- Revenue Growth
- TENX N/A
- RCG N/A
- 52 Week Low
- TENX $2.77
- RCG $1.52
- 52 Week High
- TENX $61.20
- RCG $1.90
- Technical
- Relative Strength Index (RSI)
- TENX 33.91
- RCG 58.44
- Support Level
- TENX $3.35
- RCG $2.00
- Resistance Level
- TENX $3.55
- RCG $2.12
- Average True Range (ATR)
- TENX 0.22
- RCG 0.07
- MACD
- TENX -0.03
- RCG -0.00
- Stochastic Oscillator
- TENX 0.00
- RCG 84.38
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About RCG RENN Fund Inc
RENN Fund Inc is active in the financial services domain. It is a closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, Oil and Gas, medical chemicals, botanical products, and others.